CVR 41466162Public limited company (A/S)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)Aarhus CFounded 26 Jun 2020
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about XcelCyte A/S, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexEmployees
1
CVR, 2021
Gross profit
-16.5K
DKK, annual report 2024
Result
-19.3K
DKK, annual report 2024
Equity
-18.9K
DKK, annual report 2024
LILLE FREDERIKSLUND INVEST ApSCVR 28478917, 33.3% to under 50% of capital and votes, until 17 Jul 2026
EEP CO-Investment Ltd.33.3% to under 50% of capital and votes, until 17 Jul 2026
Christian Gunni Pedersenuntil 24 Jan 2023
No current owner is registered.
CVR 2847891733.3% to under 50% of capital and votes26 Jun 2020 to 17 Jul 2026
33.3% to under 50% of capital and votes26 Jun 2020 to 17 Jul 2026
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
CVR lists no current officers for this company.
Founded 26 Jun 2020.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
Jun 2021, monthly: 1 employee, 1 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | Jul 2020 | Aug 2020 | Sep 2020 | Oct 2020 | Nov 2020 | Dec 2020 | Jan 2021 | Feb 2021 | Mar 2021 | Apr 2021 | May 2021 | Jun 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| FTE | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Series | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's headcount in CVR, not the annual report's average, which may cover a group.
Source: CVR, latest Jun 2021, published 19 Aug 2021.
The company's own figures, in DKK, from the annual reports filed in XBRL.
2024, DKK: Gross profit -16.5K, Operating profit -16.5K, Result for the year -19.3K
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
2024, DKK: Total assets 188.5K, Equity -18.9K
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
| DKK thousands | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Gross profit | -2,628 | -2,215 | -78 | -21 | -17 |
| Operating profit | -2,930 | -2,499 | -78 | -21 | -17 |
| Result for the year | -2,348 | -2,058 | -157 | -36 | -19 |
| Equity | 2,252 | 194 | 37 | 0 | -19 |
| Total assets | 2,594 | 927 | 282 | 213 | 189 |
| Employees (average) | 1 | 1 | 0 | 1 | 1 |
| Credit metrics (Dandex calculations) | |||||
| EBITDA | -2,865 | -2,451 | -78 | Not reportednote 1 | Not reportednote 1 |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | ||||
| Employee growth (vækst i antal ansatte) | Not reportednote 2 | Not reportednote 3 | -100% | 0% | 0% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||||
| Capex (investeringer i anlægsaktiver) | 258note 4 | 0note 5 | Not reportednote 6 | Not reportednote 7 | Not reportednote 7 |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||||
Not every period is a full year: 2020 covers 6 months (26 Jun to 31 Dec 2020). Changes against it compare periods of different length.
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
How each credit metric is calculated:
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
What Pro holds for XcelCyte A/S:
Have Pro? Sign in.
Amounts in DKK. Cash price is per DKK 1 of nominal capital, which a share split does not move.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| FoundingCashPaid in 4,600,000, cash price 10.00 | 10.00 | 4,600,000 | None | 460,000 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
Source: CVR, read 19 Nov 2026.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 19 Nov 2026.
7 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Likvidation sluttet, og virksomheden opløst
Likvidatorer:
Fratrådte:
Hans Henrik Højrup Bondegaard, den 17.07.2026.
Ny adresse: Søndergade 74, 5., 8000 Aarhus C
Ny kommune: Århus
Likvidation vedtaget 24.01.2023
Likvidatorer:
Tiltrådte:
Hans Henrik Højrup Bondegaard, 8000 Aarhus C, den 24.01.2023.
Bestyrelse:
Fratrådte:
Jesper Brinkmann, den 24.01.2023, Per Falholt, den 24.01.2023, David Carl Christian von Kauffmann, (formand), den 24.01.2023.
Direktion:
Fratrådte:
Christian Gunni Pedersen, den 24.01.2023.
Virksomheden tegnes af en likvidator
Virksomhedens kreditorer opfordres til at anmelde deres krav til likvidator. Krav skal anmeldes senest tre måneder fra dags dato.
Revision:
Fratrådte:
BDO STATSAUTORISERET REVISIONSAKTIESELSKAB, den 16.05.2022.
Revision:
Fratrådte:
PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB, den 24.11.2020.
Tiltrådte:
CVR-NR. 20222670 BDO STATSAUTORISERET REVISIONSAKTIESELSKAB, Havneholmen 29, 1561 København V, den 24.11.2020.
Ny adresse: Venlighedsvej 6, 2970 Hørsholm
Ny kommune: Rudersdal
Stiftelsesdato: 26.06.2020.
Virkningsdato: 26.06.2020.
Seneste vedtægtsdato: 26.06.2020.
Kapital:
kr. 460.000,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 460.000,00 til kurs 1.000,00, fuldt indbetalt.
Stiftere:
Christian Gunni Pedersen, den 26.06.2020, EEP Co-Investment Ltd., 1 Royal Plaza, Royal Avenue, St. Peter Port,, Guernsey, GY1 2HL, Storbritannien, den 26.06.2020, Neil Charles Boughton, den 26.06.2020, CVR-NR. 10147069 DB&P ApS, Hostrupsvej 2, 3060 Espergærde, den 26.06.2020, CVR-NR. 26006694 KIRKIN HOLDING ApS, Strandvejen 18, 3. th, 2100 København Ø, den 26.06.2020, CVR-NR. 28478917 LILLE FREDERIKSLUND INVEST ApS, c/o Per Falholt, Lille Frederikslund 6, 2840 Holte, den 26.06.2020, CVR-NR. 38844172 Probiomic ApS, Pile Alle 37A, Øverød, 2840 Holte, den 26.06.2020, CVR-NR. 41452935 Vivopharm Holding ApS, c/o Gert Mads Bolwig, Vilvordevej 39A, 2920 Charlottenlund, den 26.06.2020.
Bestyrelse:
David Carl Christian von Kauffmann, (formand), den 26.06.2020, Jesper Brinkmann, den 26.06.2020, Per Falholt, den 26.06.2020.
Direktion:
Christian Gunni Pedersen, den 26.06.2020.
Selskabet tegnes af den samlede bestyrelse eller af et bestyrelsesmedlem i forening med en direktør eller af formanden for bestyrelsen i forening med et bestyrelsesmedlem
Revision:
CVR-NR. 33771231 PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB, Strandvejen 44, 2900 Hellerup, den 26.06.2020.
Første regnskabsår:
26.06.2020 - 31.12.2020.
Regnskabsår:
01.01 - 31.12.
Formål:
Selskabets formål er at forske i, udvikle, producere og markedsføre medicinske, farmaceutiske, gen- og celleterapi, samt tekniske produkter og service ydelser samt anden dertil knyttet virksomhed efter bestyrelsens nærmere bestemmelse.
P-number 1025969444Søndergade 74, 8000 Aarhus C